Latest Breaking News On - He cntg nl0014040206 - Page 1 : comparemela.com

By Chris Wack Centogene N.V. said Tuesday that it has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with Lysosomal Storage Disorders. Under the renewed. | April 11, 2023

Chris wackShire pharmaceuticalsTakeda pharmaceutical coTakeda pharmaceuticalLysosomal storageDow jonesCentogenenv stock exchangePress releaseHe cntg nl0014040206